# Trevena Inc. (TRVN)

Source: https://www.quantisnow.com/company/TRVN
Generated: 2026-11-20T02:46:29.708Z

- Ticker: TRVN
- Exchange: NASDAQ
- Sector: Health Care
- Industry: Biotechnology: Pharmaceutical Preparations
- IPO year: 2014
- Website: trevena.com

## About

Trevena, Inc., a biopharmaceutical company, focuses on the development and commercialization of novel medicines for patients affected by central nervous system disorders. Its lead product candidates include OLINVYK (Oliceridine) injection, a G protein biased mu-opioid receptor (MOR) ligand for the management of moderate-to-severe acute pain; TRV027 for the treatment of acute lung injury contributing to acute respiratory distress syndrome and abnormal blood clotting in patients with COVID-19; TRV250, a G protein biased delta-opioid receptor agonist that has completed Phase I clinical study for the treatment of acute migraine; TRV734, a small molecule G protein biased ligand of the MOR that has completed Phase I clinical study for the treatment of moderate-to-severe acute and chronic pain; and TRV045, a novel S1P modulator for managing chronic pain. The company has a collaboration with Imperial College London to evaluate Trv027 in Covid-19 patients. Trevena, Inc. was incorporated in 2007 and is headquartered in Chesterbrook, Pennsylvania.

## Latest TRVN news and filings

- 2025-05-15 12:09 UTC [SEC Form 8-K] [Trevena Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Termination of a Material Definitive Agreement, Unregistered Sales of Equity Securities, Financial Statements and Exhibits](https://www.quantisnow.com/insight/trevena-inc-filed-sec-form-8-k-entry-into-a-material-6040878)
- 2025-04-08 13:20 UTC [SEC Form 25-NSE filed by Trevena Inc.](https://www.quantisnow.com/insight/sec-form-25-nse-filed-by-trevena-inc-5980877)
- 2025-03-31 20:01 UTC [SEC Form NT 10-K filed by Trevena Inc.](https://www.quantisnow.com/insight/sec-form-nt-10-k-filed-by-trevena-inc-5966868)
- 2025-02-03 21:05 UTC [SEC Form 8-K] [Trevena Inc. filed SEC Form 8-K: Leadership Update, Financial Statements and Exhibits](https://www.quantisnow.com/insight/trevena-inc-filed-sec-form-8-k-leadership-update-financial-statements-5867296)
- 2025-01-15 20:09 UTC [SEC Form 8-K] [Trevena Inc. filed SEC Form 8-K: Other Events, Financial Statements and Exhibits](https://www.quantisnow.com/insight/trevena-inc-filed-sec-form-8-k-other-events-financial-statements-5846845)
- 2024-12-06 21:39 UTC [SEC Form 3] [New insider Sutton Katrine claimed ownership of 942 shares (SEC Form 3)](https://www.quantisnow.com/insight/new-insider-sutton-katrine-claimed-ownership-of-942-shares-sec-5803963)
- 2024-11-29 12:05 UTC [SEC Form RW filed by Trevena Inc.](https://www.quantisnow.com/insight/sec-form-rw-filed-by-trevena-inc-5794298)
- 2024-11-27 21:05 UTC [SEC Form 8-K] [Trevena Inc. filed SEC Form 8-K: Leadership Update](https://www.quantisnow.com/insight/trevena-inc-filed-sec-form-8-k-leadership-update-5793439)
- 2024-11-14 21:43 UTC [SEC Schedule 13G] [Amendment: SEC Form SC 13G/A filed by Trevena Inc.](https://www.quantisnow.com/insight/amendment-sec-form-sc-13ga-filed-by-trevena-inc-5776656)
- 2024-11-07 12:15 UTC [SEC Form 10-Q] [SEC Form 10-Q filed by Trevena Inc.](https://www.quantisnow.com/insight/sec-form-10-q-filed-by-trevena-inc-5757547)
- 2024-11-07 12:05 UTC [SEC Form 8-K] [Trevena Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Leadership Update, Financial Statements and Exhibits](https://www.quantisnow.com/insight/trevena-inc-filed-sec-form-8-k-results-of-operations-and-5757482)
- 2024-11-07 12:01 UTC [Trevena Reports Third Quarter 2024 Results and Provides Business Update](https://www.quantisnow.com/insight/trevena-reports-third-quarter-2024-results-and-provides-business-update-5757435)
- 2024-10-10 21:08 UTC [SEC Form 4] [Acting CMO Demitrack Mark covered exercise/tax liability with 885 shares, decreasing direct ownership by 7% to 11,363 units (SEC Form 4)](https://www.quantisnow.com/insight/acting-cmo-demitrack-mark-covered-exercisetax-liability-with-885-shares-5722703)
- 2024-10-10 21:07 UTC [SEC Form 4] [Acting COO and CFO Shin Barry covered exercise/tax liability with 806 shares, decreasing direct ownership by 7% to 11,543 units (SEC Form 4)](https://www.quantisnow.com/insight/acting-coo-and-cfo-shin-barry-covered-exercisetax-liability-with-5722700)
- 2024-10-10 21:07 UTC [SEC Form 4] [Acting CEO Bourdow Carrie L. covered exercise/tax liability with 1,822 shares, decreasing direct ownership by 7% to 23,894 units (SEC Form 4)](https://www.quantisnow.com/insight/acting-ceo-bourdow-carrie-l-covered-exercisetax-liability-with-1822-5722698)
- 2024-10-10 20:39 UTC [SEC Form 8-K] [Trevena Inc. filed SEC Form 8-K: Leadership Update, Financial Statements and Exhibits](https://www.quantisnow.com/insight/trevena-inc-filed-sec-form-8-k-leadership-update-financial-statements-5722602)
- 2024-10-04 20:10 UTC [SEC Form 8-K] [Trevena Inc. filed SEC Form 8-K: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Regulation FD Disclosure, Financial Statements and Exhibits](https://www.quantisnow.com/insight/trevena-inc-filed-sec-form-8-k-notice-of-delisting-or-5717064)
- 2024-10-04 20:05 UTC [Trevena Announces Receipt of Nasdaq Delisting Notification](https://www.quantisnow.com/insight/trevena-announces-receipt-of-nasdaq-delisting-notification-5716968)
- 2024-09-19 20:09 UTC [SEC Schedule 13G] [SEC Form SC 13G filed by Trevena Inc.](https://www.quantisnow.com/insight/sec-form-sc-13g-filed-by-trevena-inc-5699646)
- 2024-09-17 22:36 UTC [SEC Form 4] [SVP, Chief Business Officer Yoder Robert T covered exercise/tax liability with 487 shares, decreasing direct ownership by 8% to 5,868 units (SEC Form 4)](https://www.quantisnow.com/insight/svp-chief-business-officer-yoder-robert-t-covered-exercisetax-liability-5697154)
- 2024-09-17 22:31 UTC [SEC Form 4] [SVP, CFO Shin Barry covered exercise/tax liability with 3 shares, decreasing direct ownership by 0.02% to 12,349 units (SEC Form 4)](https://www.quantisnow.com/insight/svp-cfo-shin-barry-covered-exercisetax-liability-with-3-shares-5697147)
- 2024-08-30 11:05 UTC [SEC Form 8-K] [Trevena Inc. filed SEC Form 8-K: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Financial Statements and Exhibits](https://www.quantisnow.com/insight/trevena-inc-filed-sec-form-8-k-notice-of-delisting-or-5677335)
- 2024-08-08 20:06 UTC [SEC Form 8-K] [Trevena Inc. filed SEC Form 8-K: Material Modification to Rights of Security Holders, Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Other Events, Financial Statements and Exhibits](https://www.quantisnow.com/insight/trevena-inc-filed-sec-form-8-k-material-modification-to-rights-5650506)
- 2024-08-08 20:05 UTC [Trevena Announces Reverse Stock Split](https://www.quantisnow.com/insight/trevena-announces-reverse-stock-split-5650264)
- 2024-08-08 11:15 UTC [SEC Form 10-Q] [SEC Form 10-Q filed by Trevena Inc.](https://www.quantisnow.com/insight/sec-form-10-q-filed-by-trevena-inc-5649163)
- 2024-08-08 11:05 UTC [SEC Form 8-K] [Trevena Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits](https://www.quantisnow.com/insight/trevena-inc-filed-sec-form-8-k-results-of-operations-and-5649111)
- 2024-08-08 11:00 UTC [Trevena Reports Second Quarter 2024 Results and Provides Business Update](https://www.quantisnow.com/insight/trevena-reports-second-quarter-2024-results-and-provides-business-update-5648987)
- 2024-08-01 12:00 UTC [Public Offering] [Sagimet Biosciences Announces Appointment of Anne Phillips and Jennifer Jarrett to its Board of Directors](https://www.quantisnow.com/insight/sagimet-biosciences-announces-appointment-of-anne-phillips-and-jennifer-jarrett-5637042)
- 2024-07-08 13:19 UTC [Market Chatter] [Trevena Announces Amendment To Ex-US Royalty Financing With R-Bridge Healthcare Fund; Expects $2M Payment And Potential Additional $8M Based On OLINVYK US Milestones; Liability Reduced By $10M](https://www.quantisnow.com/insight/trevena-announces-amendment-to-ex-us-royalty-financing-with-r-bridge-healthcare-5596616)
- 2024-07-08 13:16 UTC [SEC Form 8-K] [Trevena Inc. filed SEC Form 8-K: Other Events, Financial Statements and Exhibits](https://www.quantisnow.com/insight/trevena-inc-filed-sec-form-8-k-other-events-financial-statements-5596613)
- 2024-07-08 13:15 UTC [Trevena Announces $2M Non-Dilutive Financing Tranche and Reduction in Outstanding Liabilities in Connection with Existing ex-US Royalty Financing](https://www.quantisnow.com/insight/trevena-announces-2m-non-dilutive-financing-tranche-and-reduction-in-outstanding-5596600)
- 2024-06-21 12:22 UTC [Market Insight] [Why Sarepta Therapeutics Shares Are Trading Higher By Around 35%; Here Are 20 Stocks Moving Premarket](https://www.quantisnow.com/insight/why-sarepta-therapeutics-shares-are-trading-higher-by-around-35-5570110)
- 2024-06-20 20:31 UTC [Market Insight] [12 Health Care Stocks Moving In Thursday's After-Market Session](https://www.quantisnow.com/insight/12-health-care-stocks-moving-in-thursdays-after-market-session-5568960)
- 2024-06-20 18:35 UTC [Market Insight] [Dow Jumps Over 300 Points; Zapp Electric Vehicles Group Shares Spike Higher](https://www.quantisnow.com/insight/dow-jumps-over-300-points-zapp-electric-vehicles-group-shares-5568341)
- 2024-06-20 17:26 UTC [Market Insight] [Why Jabil Shares Are Trading Lower By 8%? Here Are Other Stocks Moving In Thursday's Mid-Day Session](https://www.quantisnow.com/insight/why-jabil-shares-are-trading-lower-by-8-here-are-5568200)
- 2024-06-20 16:50 UTC [Market Insight] [What's Going On With Neurological Disease Focused Trevena On Thursday?](https://www.quantisnow.com/insight/whats-going-on-with-neurological-disease-focused-trevena-on-thursday-5568121)
- 2024-06-20 16:32 UTC [Market Insight] [12 Health Care Stocks Moving In Thursday's Intraday Session](https://www.quantisnow.com/insight/12-health-care-stocks-moving-in-thursdays-intraday-session-5568087)
- 2024-06-20 16:00 UTC [Market Insight] [Gold Rises 1%; Accenture Shares Surge After Q3 Results](https://www.quantisnow.com/insight/gold-rises-1-accenture-shares-surge-after-q3-results-5568034)
- 2024-06-20 15:47 UTC [Market Chatter] [Trevena shares are trading lower, reversing after initially rising on preclinical TRV045 data.](https://www.quantisnow.com/insight/trevena-shares-are-trading-lower-reversing-after-initially-rising-on-5568008)
- 2024-06-20 12:05 UTC [Market Insight] [12 Health Care Stocks Moving In Thursday's Pre-Market Session](https://www.quantisnow.com/insight/12-health-care-stocks-moving-in-thursdays-pre-market-session-5567249)

## More

- Live page with ratings, short volume, options and peers: https://www.quantisnow.com/company/TRVN
- Earnings history: https://www.quantisnow.com/earnings/TRVN
- Dividend history: https://www.quantisnow.com/dividends/TRVN
- Insider transactions: https://www.quantisnow.com/insiders/TRVN
- Options chain: https://www.quantisnow.com/options/TRVN
- SEC 8-K filings only: https://www.quantisnow.com/company/TRVN/8-k
- RSS and alerts for TRVN: https://www.quantisnow.com/docs/rss-feeds.md
